Tie-up with Serum Institute of India key to mass production of COVID vaccines, say two pharma majors

"Together with our partner, the Serum Institute of India, we plan to supply over 300 million doses to 145 countries through COVAX in the first half of 2021 as part of our global and equitable access pledge," Ruud Dobber, president of AstraZeneca's biopharmaceuticals business, said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3kjFRnt
via IFTTT